SEC Form 4 · accession 0001214659-19-000170
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary H Slatko
Officer — SVP, Chief Medical Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 7, 2019 · 11:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398733
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $7.18 | Jan 2, 2019 | A | 75,000 | A | — | Jan 2, 2029 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1The shares underlying the options vest in three annual installments of 25%, 25% and 50% on January 2, 2020, January 2, 2021 and January 2, 2022, respectively, subject in each case to Dr. Slatko's continuous service with the Issuer from the grant date through the applicable vesting date.